Vicarious Surgical (NYSE:RBOT) Stock Rating Lowered by Wall Street Zen

Vicarious Surgical (NYSE:RBOT) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday.

Several other research analysts have also recently issued reports on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, January 21st. BTIG Research reissued a “neutral” rating on shares of Vicarious Surgical in a research note on Friday, December 12th. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus target price of $7.00.

Vicarious Surgical Price Performance

Shares of NYSE RBOT opened at $2.21 on Friday. The stock has a fifty day moving average price of $2.50 and a 200 day moving average price of $5.10. Vicarious Surgical has a 1-year low of $1.80 and a 1-year high of $16.35. The company has a market cap of $14.48 million, a PE ratio of -0.24 and a beta of 1.54.

Vicarious Surgical (NYSE:RBOT) last announced its quarterly earnings data on Wednesday, November 12th. The company reported ($1.91) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.37) by $0.46. Analysts anticipate that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Vicarious Surgical

Institutional investors and hedge funds have recently modified their holdings of the company. Connective Capital Management LLC acquired a new position in Vicarious Surgical during the third quarter worth $169,000. DNB Asset Management AS increased its position in shares of Vicarious Surgical by 12.1% in the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after buying an additional 3,154 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Vicarious Surgical by 22.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after buying an additional 3,615 shares during the last quarter. Institutional investors and hedge funds own 47.27% of the company’s stock.

About Vicarious Surgical

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.